ABSTRACT NUMBER: ESOC2026A1289 HIGH PREVALENCE BUT LOW STROKE BURDEN AMONG PATHOGENIC NOTCH3 VARIANT CARRIERS IN A POPULATION-BASED GENOMIC SCREENING COHORT

Abstract Background and aims The Jeju Genome Project (JGP) is a population-based genomic initiative integrating whole-genome sequencing with clinical data from community-dwelling adults in Jeju, South Korea. We aimed to investigate the prevalence, genotype distribution, and stroke burden associated with pathogenic NOTCH3 variants in a community-based genomic cohort. Methods Of 5,309 JGP participants, 3,001 apparently healthy community-dwelling adults were included. Whole-genome sequencing was performed using standard high-throughput platforms with a mean depth of 36.5×. Pathogenic and likely pathogenic NOTCH3 variants were identified based on ClinVar annotations. Demographic characteristics, vascular risk factors, family history of stroke, and self-reported stroke history were compared between variant carriers and non-carriers. Results Among 3,001 individuals, 39 (1.3%) carried pathogenic or likely pathogenic NOTCH3 variants. The mean age of carriers was 53.9 ± 15.3 years, and 33.3% were male, with no significant differences compared with non-carriers. Genotype distribution was dominated by the p.Arg544Cys variant (87.2%), followed by p.Arg578Cys (5.1%), p.Arg75Pro (5.1%), and p.Arg640Cys (2.6%), consistent with a strong regional founder effect. Only one carrier reported a prior history of stroke, with no significant difference compared with non-carriers (2.6% vs. 0.8%, p=0.289). Conclusions In this population-based cohort, pathogenic NOTCH3 variants were identified in more than 1% of individuals, whereas the observed burden of clinical stroke was remarkably low. These findings suggest substantial age-dependent penetrance and highlight the need for long-term follow-up to clarify lifetime stroke risk and modifying vascular factors among NOTCH3 variant carriers detected through population-based genomic screening. Conflict of interest Jay Chol Choi: nothing to disclose. Hyeon Ju Kim: nothing to disclose. JeHoon Jun: nothing to disclose. Sungwoong Jho: nothing to disclose.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.626
Primary Topic
Cerebrovascular and genetic disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1289 HIGH PREVALENCE BUT LOW STROKE BURDEN AMONG PATHOGENIC NOTCH3 VARIANT CARRIERS IN A POPULATION-BASED GENOMIC SCREENING COHORT

JeHoon Jun, Jay Chol Choi, Sungwoong Jho, Hyeon Ju Kim
European Stroke Journal
Cerebrovascular and genetic disorders
article

ABSTRACT NUMBER: ESOC2026A1289 HIGH PREVALENCE BUT LOW STROKE BURDEN AMONG PATHOGENIC NOTCH3 VARIANT CARRIERS IN A POPULATION-BASED GENOMIC SCREENING COHORT

JeHoon Jun, Jay Chol Choi, Sungwoong Jho, Hyeon Ju Kim
article en

Abstract

Abstract Background and aims The Jeju Genome Project (JGP) is a population-based genomic initiative integrating whole-genome sequencing with clinical data from community-dwelling adults in Jeju, South Korea. We aimed to investigate the prevalence, genotype distribution, and stroke burden associated with pathogenic NOTCH3 variants in a community-based genomic cohort. Methods Of 5,309 JGP participants, 3,001 apparently healthy community-dwelling adults were included. Whole-genome sequencing was performed using standard high-throughput platforms with a mean depth of 36.5×. Pathogenic and likely pathogenic NOTCH3 variants were identified based on ClinVar annotations. Demographic characteristics, vascular risk factors, family history of stroke, and self-reported stroke history were compared between variant carriers and non-carriers. Results Among 3,001 individuals, 39 (1.3%) carried pathogenic or likely pathogenic NOTCH3 variants. The mean age of carriers was 53.9 ± 15.3 years, and 33.3% were male, with no significant differences compared with non-carriers. Genotype distribution was dominated by the p.Arg544Cys variant (87.2%), followed by p.Arg578Cys (5.1%), p.Arg75Pro (5.1%), and p.Arg640Cys (2.6%), consistent with a strong regional founder effect. Only one carrier reported a prior history of stroke, with no significant difference compared with non-carriers (2.6% vs. 0.8%, p=0.289). Conclusions In this population-based cohort, pathogenic NOTCH3 variants were identified in more than 1% of individuals, whereas the observed burden of clinical stroke was remarkably low. These findings suggest substantial age-dependent penetrance and highlight the need for long-term follow-up to clarify lifetime stroke risk and modifying vascular factors among NOTCH3 variant carriers detected through population-based genomic screening. Conflict of interest Jay Chol Choi: nothing to disclose. Hyeon Ju Kim: nothing to disclose. JeHoon Jun: nothing to disclose. Sungwoong Jho: nothing to disclose.

European Stroke JournalVol. 11(Supplement_1)
Syneos Health (South Korea) (KR), Genomics (United Kingdom) (GB), Jeju National University Hospital (KR)
Openalex Percentile: Top 8%
Cerebrovascular and genetic disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.